Standard BioTools Statistics
NASDAQ: LABIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
0.631+0.0173 (+2.82%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Standard BioTools by the numbers
Standard BioTools has a market capitalization of $249.1 million based on 394.79M shares outstanding. With trailing EPS of $-0.09, Standard BioTools is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.5% below its 50-day average and 26.0% below its 200-day average.
Average daily trading volume is 1.16M shares, or about $734,802 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LAB valuation vs. peer median
| Metric | LAB | Peer median | Difference |
|---|---|---|---|
| Market cap | $249.11M | $38.49M | +547% |
| Avg. volume | 1.16M | 649.32K | +79% |
Peer median across 8 companies: NAUT, QTRX, SEER, HBIO, RPID, PRPO, EYPT, CIRC.
Valuation
- Market cap
- $249.11M
- Price / sales (latest FY)
- 2.92
- EPS (TTM)
- $-0.09
- Shares outstanding
- 394.79M
Price and trading
- Previous close
- 0.6137
- Open
- 0.629
- Day range
- 0.5729 – 0.65
- 52-week range
- 0.39 – 1.72
- 52-week change
- -54.28%
- 200-day moving average
- 0.8528
- Beta
- —
- Volume
- 2.81M
- Average volume
- 1.16M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 249.11M
- Forward Pe
- -63.10
- Eps
- -0.09
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.72
- Week52 Low
- 0.39
- Avg Volume
- 1.16M
- Shares Outstanding
- 394.79M
- Ma50
- 0.67
- Ma200
- 0.85
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -63.31%
- Pct From52w Low
- 61.79%